Inge M. Westra

443 total citations
16 papers, 313 citations indexed

About

Inge M. Westra is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Inge M. Westra has authored 16 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Inge M. Westra's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Parasite Biology and Host Interactions (3 papers). Inge M. Westra is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Parasite Biology and Host Interactions (3 papers). Inge M. Westra collaborates with scholars based in Netherlands, United States and United Kingdom. Inge M. Westra's co-authors include Geny M. M. Groothuis, Peter Olinga, Dorenda Oosterhuis, Marjolijn T. Merema, Sanja Dragović, Viktoriia Starokozhko, Henricus A. M. Mutsaers, Theerut Luangmonkong, Koert P. de Jong and Pauline Meij and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Clinical Cancer Research.

In The Last Decade

Inge M. Westra

14 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge M. Westra Netherlands 9 115 76 66 52 50 16 313
Ibrahim El‐Dosoky Egypt 13 151 1.3× 160 2.1× 59 0.9× 43 0.8× 10 0.2× 37 357
Chenghong Yin China 11 150 1.3× 120 1.6× 130 2.0× 38 0.7× 23 0.5× 27 461
Yushan Ren China 12 37 0.3× 59 0.8× 128 1.9× 16 0.3× 14 0.3× 36 355
Zhiyuan Wu China 9 105 0.9× 166 2.2× 79 1.2× 47 0.9× 9 0.2× 13 304
Masami Kuniyoshi Japan 9 118 1.0× 239 3.1× 56 0.8× 74 1.4× 9 0.2× 13 428
Lunli Zhang China 10 94 0.8× 106 1.4× 75 1.1× 50 1.0× 47 0.9× 27 299
Qing‐He Nie China 12 95 0.8× 104 1.4× 75 1.1× 20 0.4× 20 0.4× 31 320
Abdel‐Baset Halim United States 10 28 0.2× 44 0.6× 159 2.4× 54 1.0× 8 0.2× 14 388
Mohammad Ali‐Hassanzadeh Iran 12 38 0.3× 82 1.1× 107 1.6× 57 1.1× 7 0.1× 34 419
Jiaquan Huang China 9 86 0.7× 105 1.4× 27 0.4× 16 0.3× 20 0.4× 25 198

Countries citing papers authored by Inge M. Westra

Since Specialization
Citations

This map shows the geographic impact of Inge M. Westra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge M. Westra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge M. Westra more than expected).

Fields of papers citing papers by Inge M. Westra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge M. Westra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge M. Westra. The network helps show where Inge M. Westra may publish in the future.

Co-authorship network of co-authors of Inge M. Westra

This figure shows the co-authorship network connecting the top 25 collaborators of Inge M. Westra. A scholar is included among the top collaborators of Inge M. Westra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge M. Westra. Inge M. Westra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Verdegaal, Els M.E., Monique K. van der Kooij, Caroline E. van der Minne, et al.. (2025). Effective TIL Therapy for Patients with Checkpoint-Resistant Melanoma without Lymphodepleting Regimens Requires IFNα. Clinical Cancer Research. 31(13). 2628–2638. 1 indexed citations
2.
Tienen, Florence H. J. van, Janneke G. J. Hoeijmakers, Christiaan van der Leij, et al.. (2025). Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1/2 human clinical study. Molecular Therapy. 33(10). 5061–5072.
3.
Westra, Inge M., Richard P. Davis, Françoise Carlotti, et al.. (2024). Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system. Cytotherapy. 26(9). 1105–1117. 4 indexed citations
4.
Verdegaal, Els M.E., Saskia J. Santegoets, Marij J.P. Welters, et al.. (2023). Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(11). e007697–e007697. 16 indexed citations
5.
Hoogerwerf, Marie-Astrid, Jacqueline J. Janse, Yvonne C. M. Kruize, et al.. (2023). Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial. The Lancet Microbe. 4(12). e1024–e1034. 8 indexed citations
6.
Hoogerwerf, Marie-Astrid, Jan Pieter R. Koopman, Jacqueline J. Janse, et al.. (2020). A Randomized Controlled Trial to Investigate Safety and Variability of Egg Excretion After Repeated Controlled Human Hookworm Infection. The Journal of Infectious Diseases. 223(5). 905–913. 12 indexed citations
7.
Janse, Jacqueline J., Marijke C. C. Langenberg, Arifa Ozir‐Fazalalikhan, et al.. (2018). Establishing the Production of Male Schistosoma mansoni Cercariae for a Controlled Human Infection Model. The Journal of Infectious Diseases. 218(7). 1142–1146. 22 indexed citations
8.
Westra, Inge M., Henricus A. M. Mutsaers, Theerut Luangmonkong, et al.. (2016). Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis. Toxicology in Vitro. 35. 77–85. 54 indexed citations
9.
Govorukhina, Natalia, G. Zwanenburg, Huub C. J. Hoefsloot, et al.. (2016). Identification of Analytical Factors Affecting Complex Proteomics Profiles Acquired in a Factorial Design Study with Analysis of Variance: Simultaneous Component Analysis. Analytical Chemistry. 88(8). 4229–4238. 8 indexed citations
10.
Westra, Inge M., Dorenda Oosterhuis, Geny M. M. Groothuis, & Peter Olinga. (2014). The Effect of Antifibrotic Drugs in Rat Precision-Cut Fibrotic Liver Slices. PLoS ONE. 9(4). e95462–e95462. 45 indexed citations
11.
Westra, Inge M.. (2014). Precision-cut liver slices: an ex vivo model for the early onset and end-stage of liver fibrosis. Data Archiving and Networked Services (DANS). 3 indexed citations
12.
Westra, Inge M., Dorenda Oosterhuis, Geny M. M. Groothuis, & Peter Olinga. (2013). Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicology and Applied Pharmacology. 274(2). 328–338. 66 indexed citations
13.
Westra, Inge M., et al.. (2013). Human Precision-Cut Liver Slices as anex VivoModel to Study Idiosyncratic Drug-Induced Liver Injury. Chemical Research in Toxicology. 26(5). 710–720. 49 indexed citations
14.
Westra, Inge M., Dorenda Oosterhuis, Geny M. M. Groothuis, & Peter Olinga. (2011). INDUCTION OF FIBROTIC MARKERS IN AN IN VITRO MODEL OF LIVER FIBROSIS. Data Archiving and Networked Services (DANS). 54. 3 indexed citations
15.
Westra, Inge M., et al.. (2011). Rat and human intestinal slices as a model for intestinal fibrosis in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 17. S76–S76. 1 indexed citations
16.
Faas, Marijke M., Maria G. van Pampus, Inge M. Westra, et al.. (2010). Plasma from preeclamptic women activates endothelial cells via monocyte activation in vitro. Journal of Reproductive Immunology. 87(1-2). 28–38. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ibrahim El‐Dosoky Breakdown of academic impact, for papers by Chenghong Yin Breakdown of academic impact, for papers by Yushan Ren Breakdown of academic impact, for papers by Zhiyuan Wu Breakdown of academic impact, for papers by Masami Kuniyoshi Breakdown of academic impact, for papers by Lunli Zhang Breakdown of academic impact, for papers by Qing‐He Nie Breakdown of academic impact, for papers by Abdel‐Baset Halim Breakdown of academic impact, for papers by Mohammad Ali‐Hassanzadeh Breakdown of academic impact, for papers by Jiaquan Huang
Rankless by CCL
2026